IL22 and neoplasm: Nicholas et al. found that IL-22, a cytokine expressed by Th17 cells, stimulates angiogenesis by activating ERK and Stat3 pathways and acts directly on endothelial cells to induce tumor angiogenesis, thereby promoting tumor metastasis [159].